Chemotherapy regimen choice and patient outcomes in early-stage triple-negative breast cancer: a retrospective analysis

BACKGROUND: Triple-negative breast cancer (TNBC) is associated with a poor prognosis when compared to hormone receptor–positive breast cancers. Anthracycline-based regimens (ABRs) are mainstay for treatment of non-metastatic TNBC. However, anthracyclines are associated with an increased risk of pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghafouri, Sanaz N., Nayeri, Rebecca W., McAndrew, Nicholas P., Hurvitz, Sara A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988670/
https://www.ncbi.nlm.nih.gov/pubmed/35401793
http://dx.doi.org/10.1177/17588359221085556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988670/
https://www.ncbi.nlm.nih.gov/pubmed/35401793
http://dx.doi.org/10.1177/17588359221085556

Ejemplares similares